Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2020, Vol. 47 Issue (2): 166-173    DOI: 10.31083/j.ceog.2020.02.5148
Original Research Previous articles | Next articles
Comparison between antral follicle count and anti-Müllerian hormonal level in the prediction of ovarian response and pregnancy outcome in intracytoplasmic sperm injection patients: implications in personalizing ovarian stimulation
H. Saleh1, F. Moiety1, A.F. Agameya1, Y. Elkassar1, R.M. El Sharakwy2, D. Zeidan3, H. Elmeligy4, *()
1 Department of OB/GYN, Shatby University Hospital, Alexandria University, Alexandria
2 Medical Research Institute, Alexandria, Egypt
3 Leeds Teaching Hospitals NHS Trust, Leeds, England
4 St. Elisabeth Hospital, Damme, Germany
Download:  PDF(2287KB)  ( 239 ) Full text   ( 10 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Antral follicle count (AFC) and anti-Müllerian Hormone (AMH) are considered the best markers of ovarian reserve and ovarian response to stimulation. It is not clear whether they complement each other or act interchangeably in predicting ovarian response and individualizing gonadotropin dosage. Objective: To compare the predictive value of AFC and serum AMH for ovarian response and pregnancy outcome in intracytoplasmic sperm injection (ICSI) patients stimulated by an antagonist protocol. Moreover, to decide if measuring both markers adds to the power of predicting a response. Materials and Methods: A prospective diagnostic test study of infertile women. Setting: A private in vitro fertilization unit, Agial Hospital, Alexandria, Egypt. Women aged 20–39 years (n = 700) and undergoing their first ICSI cycle were included in this study. AFC and AMH measurements were taken. All patients were stimulated with a fixed antagonist protocol with a starting dose of 200 IU of recombinant follicle stimulating hormone (rFSH). Main outcome measures included the number of oocytes retrieved and the clinical pregnancy rate. Results: Age, AMH, AFC, and a score combining both AMH and AFC (AMHxAFC) were statistically significant discriminators of the occurrence of an excessive response. The cutoff values for AMH, AFC, and AMHxAFC were > 3.75 ng/mL, > 23, and > 64.8. While AMH and AFC were equally effective in predicting an excessive response, the combined score AMHxAFC was significantly better than AFC or AMH alone. AMH, AFC, and AMHxAFC were significantly better predictors of an excessive response than age. Age, AFC, AMH, and the AMHxAFC were statistically significant discriminators of the occurrence of a poor response; however, AFC was the best predictor of a poor response, with a cutoff < 12. Age, AFC, and AMH were statistically significant discriminators of the occurrence of pregnancy, yet their predictive power is low. Conclusion: Measuring both AMH and AFC adds to their predictive power for a high or an excessive response. AFC alone is an excellent predictor of a poor response and is significantly better than age and AMH. Age, AMH, and AFC have poor predictive power for pregnancy.
Key words:  Anti-Müllerian hormone      Ovarian reserve      Ovarian response      Ovarian stimulation     
Published:  15 April 2020     
*Corresponding Author(s):  H. ELMELIGY     E-mail:  haythamelmeligy@hotmail.com

Cite this article: 

H. Saleh, F. Moiety, A.F. Agameya, Y. Elkassar, R.M. El Sharakwy, D. Zeidan, H. Elmeligy. Comparison between antral follicle count and anti-Müllerian hormonal level in the prediction of ovarian response and pregnancy outcome in intracytoplasmic sperm injection patients: implications in personalizing ovarian stimulation. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 166-173.

URL: 

https://ceog.imrpress.com/EN/10.31083/j.ceog.2020.02.5148     OR     https://ceog.imrpress.com/EN/Y2020/V47/I2/166

[1] J.H. Check, E. Chang, R. Cohen. A case report supporting the concept that a role for the anti-Müllerian hormone (AMH) in normal folliculogenesis is to diminish the biological activity of follicle stimulating hormone (FSH)[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 620-621.
[2] Hue HJ, Kim SK, Choi JY, Suh DH, Kim KD, No JH, Lee JR, Jee BC, Kim YB, Jeon HW. Previous ovarian surgery increases the risk of tubal factor infertility[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 84-88.
[3] P. Bakas, M. Simopoulou, P. Panagopoulos, N. Salakos, Ch. Siristatidis. Luteal phase progesterone and estradiol concentrations and their relation to the outcome of IVF/ICSI cycles with controlled ovarian stimulation[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 727-730.
[4] N. Eamudomkarn, L. Salang, K. Seejorn, P. Kleebkaow. Comparison of impact on ovarian reserve between laparoscopic and laparotomy ovarian cystectomy[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 779-783.
[5] L.-S. Wang, X.-L. Zhao, X.-A. Cai, G.-F. Fu. Age specific reference intervals of serum anti-Müllerian hormone concentration of 1,253 women with healthy females in infertility center[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 526-530.
[6] A.H. Kaya, E. Tekgunduz, S. Akpınar, G. Bozdağ, T.N. Yiğenoğlu, A. Merdin, S. Namdaroglu, O. Kayıkcı, F. Altuntaş. Assessment of ovarian reserve with anti-Mullerian hormone in women following allogeneic hematopoietic cell transplantation[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 127-130.
[7] Haining Luo, Kun Yang, Ying Han, Yunshan Zhang. A case report of clinical pregnancy in which oocyte retrieval was carried out in the early follicular phase of the menstrual cycle[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(4): 629-631.
[8] P. Bakas, M. Creatsa, P. Panagopoulos, N. Vlahos, E. Papadakis, M. Simopoulou. Outcome and recurrence risk of premature progesterone rise in IVF/ICSI cycles using GnRH antagonists for pituitary down-regulation[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(1): 44-47.
[9] J. Micic, L. Surlan, J. Dotlic, N. Milic, S. Vidakovic, N. Radunovic. Ovarian response predictive model in different controlled ovarian stimulation protocols for IVF/ICSI treatment[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(6): 923-928.
[10] H.U. Yuvacı, S. Uysal, H. Haltaş, B. Sırav, C.I. Duvan, N. Turhan, N. Seyhan. The effect of non-ionizing radiation on the ovarian reserves of female rats[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(4): 605-610.
[11] A. Eser, D. Hizli, M. Namuslu, H. Haltas, N. Kosus, A. Kosus, H. Kafali. Protective effect of curcumin on ovarian reserve in a rat ischemia model: an experimental study[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(3): 453-457.
[12] E. Caglayan, E. Okyay, T. Bodur, C. Ertugrul, E. Koyun, M. Kovali, E. Dogan, B. Gulekli. Hysterosalpingography prior to the gonadotropin stimulated intrauterine insemination improves clinical pregnancy rates in women with unexplained infertility[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(1): 65-69.
No Suggested Reading articles found!